In human solid tumors, a polymorphism in the SIPA1 gene causing higher RapGAP activity was associated with high metastatic potential of breast cancer [40], and SIPA1 expression was found to positively correlate with disease progression and metastasis in human prostate cancer [41]. The gene discussed is SIPA1; the disease is prostate cancer.